Learnings from Throwing Paint at the Wall for COVID-19 with an SGLT2 Inhibitor

Katherine R Tuttle^{1

2}

Affiliations

¹ Providence Medical Research Center, Providence Health Care, Spokane, Washington, and.
² Nephrology Division, Kidney Research Institute, Institute of Translational Health Sciences, University of Washington, Seattle, Washington.

Editorial

Katherine R Tuttle. Clin J Am Soc Nephrol. 2022 May.

. 2022 May;17(5):628-630.

doi: 10.2215/CJN.03250322. Epub 2022 Apr 28.

Katherine R Tuttle^{1

2}

¹ Providence Medical Research Center, Providence Health Care, Spokane, Washington, and.
² Nephrology Division, Kidney Research Institute, Institute of Translational Health Sciences, University of Washington, Seattle, Washington.

No abstract available

Keywords: COVID-19; GFR; SARS-CoV-2; SGLT2; acute kidney injury; dapagliflozin; pandemic; safety; sodium-glucose cotransporter 2.

Comment on

Dapagliflozin and Kidney Outcomes in Hospitalized Patients with COVID-19 Infection: An Analysis of the DARE-19 Randomized Controlled Trial.
Heerspink HJL, Furtado RHM, Berwanger O, Koch GG, Martinez F, Mukhtar O, Verma S, Gasparyan SB, Tang F, Windsor SL, de Souza-Dantas VC, Del Sueldo M, Frankel R, Javaheri A, Maldonado RA, Morse C, Mota-Gomes M, Shemin D, Silva OL Jr, Tognon AP, Twahirwa M, Buenconsejo J, Esterline R, Oscarsson J, Ambery P, Langkilde AM, Kosiborod MN. Heerspink HJL, et al. Clin J Am Soc Nephrol. 2022 May;17(5):643-654. doi: 10.2215/CJN.14231021. Epub 2022 Apr 28. Clin J Am Soc Nephrol. 2022. PMID: 35483733 Free PMC article. Clinical Trial.

1. Rubin EJ: Expression of concern: Mehra MR et al. Cardiovascular disease, drug therapy, and mortality in Covid-19. N Engl J Med 382: 2464, 2020 - PMC - PubMed
1. Saag MS: Misguided use of hydroxychloroquine for COVID-19: The infusion of politics into science. JAMA 324: 2161–2162, 2020 - PubMed
1. Hill A, Garratt A, Levi J, Falconer J, Ellis L, McCann K, Pilkington V, Qavi A, Wang J, Wentzel H: Retraction to: Meta-analysis of randomized trials of ivermectin to treat SARS-CoV-2 infection. Open Forum Infect Dis 9: ofac056, 2022 - PMC - PubMed
1. Neuen BL, Young T, Heerspink HJL, Neal B, Perkovic V, Billot L, Mahaffey KW, Charytan DM, Wheeler DC, Arnott C, Bompoint S, Levin A, Jardine MJ: SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: A systematic review and meta-analysis. Lancet Diabetes Endocrinol 7: 845–854, 2019 - PubMed
1. Kang A, Jardine MJ: SGLT2 inhibitors may offer benefit beyond diabetes. Nat Rev Nephrol 17: 83–84, 2021 - PubMed